Page last updated: 2024-10-29

ketoconazole and Hospital-Acquired Condition

ketoconazole has been researched along with Hospital-Acquired Condition in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hernandez-Bures, A1
White, AG1
Riordan, L1
Brito, JP1
Singh, E1
Basu, A1

Other Studies

2 other studies available for ketoconazole and Hospital-Acquired Condition

ArticleYear
Presumptive iatrogenic hypoadrenocorticism induced by high-dose ketoconazole administration in a dog.
    Journal of veterinary internal medicine, 2019, Volume: 33, Issue:5

    Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Animals; Antifungal Agents; Dermatomycoses; Dog

2019
Iatrogenic heart block during treatment of a patient with Cushing's syndrome: report of a case.
    Endocrine, 2012, Volume: 41, Issue:2

    Topics: Aged, 80 and over; Alkalosis; Antihypertensive Agents; Cushing Syndrome; Cytochrome P-450 CYP3A; Cyt

2012